The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online

OD6 Metals rediscovers ultra high-grade Big Jim fluorspar lode

OD6 Metals has rediscovered the historically significant high-grade Big Jim fluorspar lode at its Quinn project…
The Market Online Video

The ASX Today: Aussie market caught between Wall Street records, unstoppable oil – and all on Budget Day

Hello and welcome to HotCopper’s The ASX Today, I’m Seja Al Zaidi.
HotCopper Daily Market Trends Graphic

Tuesday’s HotCopper trends: Elevtra, Metallium, EV Resources, and other daily topics

the S&P/ASX 200 is lower today, dropping 35.20 points or 0.40% to 8,666.60. Bottom performing stocks…

Hazer Group signs MoU to assess Australian energy independence

Hazer Group has entered into a non-binding MoU to assess opportunities for developing low carbon liquid…